Paul Rivard
2023
In 2023, Paul Rivard earned a total compensation of $578.3K as Former Chief Legal Officer at Akers Biosciences, a 207% increase compared to previous year.
Compensation breakdown
| Option Awards | $235,245 |
|---|---|
| Salary | $242,209 |
| Other | $100,819 |
| Total | $578,273 |
Rivard received $242.2K in salary, accounting for 42% of the total pay in 2023.
Rivard also received $235.2K in option awards and $100.8K in other compensation.
Rankings
In 2023, Paul Rivard's compensation ranked 1,864th out of 3,006 executives tracked by ExecPay. In other words, Rivard earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,864 out of 3,006 | 38th |
Division Manufacturing | 1,074 out of 1,650 | 35th |
Major group Chemicals And Allied Products | 672 out of 918 | 27th |
Industry group Drugs | 655 out of 881 | 26th |
Industry In Vitro and In Vivo Diagnostic Substances | 5 out of 14 | 64th |
Source: SEC filing on November 1, 2024.
Rivard's colleagues
We found three more compensation records of executives who worked with Paul Rivard at Akers Biosciences in 2023.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021